{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:58:21Z","timestamp":1774925901202,"version":"3.50.1"},"reference-count":26,"publisher":"Scientific Scholar","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"abstract":"\n Background & objectives:<\/jats:title>\n \n Mycobacterium w<\/jats:italic> (M.w) is a saprophytic cultivable mycobacterium and shares several antigens with M. tuberculosis<\/jats:italic>. It has shown good immunomodulation in leprosy patients. Hence in the present study, the efficacy of M.w immunotherapy, alone or in combination with multi drug chemotherapeutic regimens was investigated against drug sensitive M. tuberculosis<\/jats:italic> H37Rv and three clinical isolates with variable degree of drug resistance in mice.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n BALB\/c mice were infected with M. tuberculosis<\/jats:italic> H37Rv (susceptible to all first and second line drugs) and three clinical isolates taken from the epository of the Institute. The dose of 200 bacilli was used for infection via respiratory route in an aerosol chamber. Chemotherapy (5 days\/wk) was given one month after infection and the vaccinated group was given a dose of 1\u00d7107<\/jats:sup> bacilli by subcutaneous route. Bacterial load was measured at 4 and 6 wk after initiation of chemotherapy.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n M.w when given along with chemotherapy (4 and 6 wk) led to a greater reduction in the bacterial load in lungs and other organs of TB infected animals compared to. However, the reduction was significantly (P<\/jats:italic><0.05) more in terms of colony forming units (cfu) in both organs (lungs and spleen).<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n M.w (as immunomodulator) has beneficial therapeutic effect as an adjunct to chemotherapy.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/0971-5916.90999","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T06:42:36Z","timestamp":1324363356000},"page":"696-703","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":30,"title":["Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis"],"prefix":"10.25259","volume":"134","author":[{"given":"Jaya","family":"Faujdar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushpa","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Natrajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.S.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.M","family":"Katoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.D.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-18-20241212","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2471\/BLT.08.058453","article-title":"Trends in tuberculosis incidence and their determinants in 134 countries","volume":"87","author":"Dye","year":"2009","journal-title":"Bull World Health Organ"},{"key":"R2-18-20241212","first-page":"494","article-title":"Patterns of anti-tuberculosis drug resistanceamong HIV infected patients in Maputo, Mozambique, 2002-2003","volume":"9","author":"Nunes","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"R5-18-20241212","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implication of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"R6-18-20241212","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/14760584.7.5.635","article-title":"Tuberculosis: Vaccine in pipeline","volume":"7","author":"Ly","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"R7-18-20241212","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.vaccine.2007.01.112","article-title":"Current status of TB vaccines","volume":"25","author":"Gupta","year":"2007","journal-title":"Vaccine"},{"key":"R8-18-20241212","first-page":"1","article-title":"Vaccines for Mycobacterial diseases: A review","volume":"52","author":"Katoch","year":"2000","journal-title":"Punjab Univ Res Bull"},{"key":"R9-18-20241212","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tube.2006.05.004","article-title":"Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait","volume":"87","author":"Ahmed","year":"2007","journal-title":"Tuberculosis"},{"key":"R10-18-20241212","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0264-410X(91)90309-T","article-title":"Resistance to inoculation of Mycobacetrium tuberculosis H37Rv in mice of different inbred strains following immunization with a leprosy vaccine based on Mycobaceterium w","volume":"9","author":"Singh","year":"1991","journal-title":"Vaccine"},{"key":"R11-18-20241212","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0264-410X(90)90134-8","article-title":"Immuotherapeutic effects of vaccine based on a saprophytic cultivable Mycobacterium w, in multi-bacillary leprosy patients","volume":"8","author":"Talwar","year":"1990","journal-title":"Vaccine"},{"key":"R12-18-20241212","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.vaccine.2004.03.037","article-title":"10-12 years follow-up of highly bacillated BL\/LL leprosy patients on combined chemotherapy and immunotherapy","volume":"22","author":"Katoch","year":"2004","journal-title":"Vaccine"},{"key":"R13-18-20241212","first-page":"67","article-title":"Continuing challenges in tuberculosis research","volume":"39","author":"Talwar","year":"1992","journal-title":"Indian J Tuberc"},{"key":"R14-18-20241212","first-page":"191","article-title":"Effect of an immunomodulator containing Mycobacterium w on sputum conversion in pulmonary tuberculosis","volume":"100","author":"Patel","year":"2002","journal-title":"J Indian Med Assoc"},{"key":"R15-18-20241212","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1128\/JCM.39.6.2102-2109.2001","article-title":"Differentiation of mycobacterial species by PCR-restriction analysis of DNA (342 base pairs) of the RNA polymerase gene (rpoB)","volume":"39","author":"Kim","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R16-18-20241212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1128\/jcm.31.2.175-178.1993","article-title":"Rapid identification of Mycobacteria to the species level by PCR and restriction enzyme analysis","volume":"31","author":"Telenti","year":"1993","journal-title":"J Clin Microbiol"},{"key":"R17-18-20241212","first-page":"155","article-title":"Rapid identification of mycobacteria by gene amplification restriction analysis technique targeting 16S-23S ribosomal DNA spacer and flanking regions","volume":"125","author":"Katoch","year":"2007","journal-title":"Indian J Med Res"},{"key":"R18-18-20241212","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R19-18-20241212","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/AAC.47.11.3616-3619.2003","article-title":"Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method","volume":"47","author":"Martin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-18-20241212","first-page":"1","article-title":"Modulation of cytokine milieu in lungs by recombinant BCG over expressing Ag85C confers enhanced and long lasting protection against tuberculosis","volume":"3","author":"Jain","year":"2008","journal-title":"PLoS Pathogen"},{"key":"R21-18-20241212","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CMR.8.4.496","article-title":"Antimicrobial agent resistance in mycobacteria: molecular genetic insights","volume":"8","author":"Musser","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"R22-18-20241212","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/AAC.49.7.2816-2821.2005","article-title":"Imipenem for treatment of tuberculosis in mice and humans","volume":"49","author":"Chambers","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-18-20241212","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1128\/AAC.43.10.2356","article-title":"Evaluation of rifapentine in long-term treatment regimens for tuberculosis in mice","volume":"43","author":"Lenaerts","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-18-20241212","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1128\/AAC.37.11.2344","article-title":"Therapy of mutidrug-resistant lesions from studies with mice","volume":"37","author":"Klemens","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"R25-18-20241212","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/IAI.00526-08","article-title":"Immunogenicity and protective efficacy of Mycobacterium w against M. tuberculosis in mice immunized with live versus heat killed M. w by the aerosol or parenteral route","volume":"77","author":"Gupta","year":"2009","journal-title":"Infect Immun"},{"key":"R26-18-20241212","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1128\/AAC.00766-06","article-title":"Combination of R207010 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration","volume":"50","author":"Lounis","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R27-18-20241212","first-page":"3091","article-title":"The adverse reaction of anti-tuberculosis drugs and its management","volume":"56","author":"Wada","year":"1998","journal-title":"Nippon Rinsho"},{"key":"R28-18-20241212","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/AAC.46.2.443-450.2002","article-title":"Molecular characterization of multidrug-resistant isolates of tuberculosis from patients in north India","volume":"46","author":"Siddiqi","year":"2002","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201134050-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:07:39Z","timestamp":1751497659000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/mycobacterium-indicus-pranii-as-stand-alone-or-adjunct-immunotherapeutic-in-treatment-of-experimental-animal-tuberculosis\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.4103\/0971-5916.90999","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}